Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
0 hedge funds and large institutions have $0 invested in Zymergen Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 82 closing their positions.
100% less funds holding
Funds holding: 86 → 0 (-86)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $168M → $0 (-$168M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 82
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$74M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$20.8M |
| 3 |
Morgan Stanley
New York
|
-$9.3M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$7.84M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.77M |
ZY Hedge Fund Activity: Q4 2022 in Review
0 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q4 2022, worth a combined $0 — down 100% from $168M a quarter earlier.
Sellers outnumbered buyers: 82 funds closed out of ZY and 0 opened new positions — a net loss of 82 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was SB Investment Advisers (UK), exiting entirely with an estimated $74M sold.
- 0 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q4 2022, down from 86 in Q3 2022.
- Funds reported $0 of Zymergen Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Zymergen Inc. Common Stock positions in Q4 2022 and 82 closed out, a net change of -82 holders.
- The largest Zymergen Inc. Common Stock seller in Q4 2022 was SB Investment Advisers (UK), an estimated $74M sold.
Based on aggregated 13F filings for Q4 2022.